Formation and characterization of β-cyclodextrin (β-CD) – polyethyleneglycol (PEG) – polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug
Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) consist of cores made of iron oxides that can be targeted to the required area through external magnets. They have received much attention over the past decade because of their unique magnetic properties such as superparamagnetism, high field irreversibility, high saturation field, extra anisotropy contributions or shifted loops after field cooling [1], small size [2], limited toxicity [3], low cost of production [4] and ease of separation and detection [5], [6]. They have been garnering extensive attention in several biomedical applications, including magnetic resonance image (MRI) contrast agents [7], magnetic ferrofluids for hyperthermia [8], targeted drug delivery [9], and magnetically assisted separation [10]. To increase its stability, biocompatibility, prevent nanoparticle agglomeration and decrease the uptake by the reticuloendothelial system (RES), the surface of SPION has been coated by many types of hydrophilic materials and/or biocompatible polymers such as polyethyleneimine (PEI) [11], dextran, polyethylene glycol (PEG), poly-vinyl alcohol (PVA), chitosan, and others [12], [13], [14], [15], [16], [17]. The usage of SPIONs are considered to be a better carrier for the drug delivery system in the destined location as there were a number of side effects in the conventional oral delivery and injection of drug.
5-Fluorouracil (5-FU) is one of the oldest but still most extensively used anti-neoplastic agents. It is an antimetabolite of the pyrimidine analogue type with a low molecular weight, which is broadly used in the treatment of various kinds of solid tumors (such as the cancer of stomach, intestine, colon, pancreas, ovary, breast, etc.), alone or in combination chemotherapy regimes. In addition, an endurable therapeutic effect is impossible as it has a short in-vivo half-life [18]. To attain an effective clinical blood drug concentration, people very much opt to enhance drug mass or administer the drug to patients continually to enhance the toxic side effect of 5-FU [19]. To resolve this shortcoming, various microparticles (MPs) and nanoparticles encapsulating 5-FU have been prepared to control 5-FU to release slowly over certain ranges of time [20], [21], [22], [23].
β-Cyclodextrin (β-CD) is a type of cyclic oligosaccharides consisting of seven glucose units with lipophilic central cavities and a hydrophilic outer surface. It can be widely used in pharmaceutical excipient to improve the solubility, stability, and bioavailability of hydrophobic and biomolecular drugs [24], [25], [26], [27], [28]. It has been selected for encapsulation of 5-FU because it is a semi-natural product with extremely low toxicity and will enhance drug delivery through biological membranes [29]. Polyethyleneglycol (PEG) is commonly used in pharmaceutical and biomedical applications because of its exceptional physico-chemical and biological properties including hydrophilic property, solubility, non-toxicity, ease of chemical modification and absence of antigenicity and immunogenicity. It is, a classic pharmacokinetic stabilizer, which has been used to prolong magnetic nanoparticles circulations half-times in vivo, but almost exclusively for magnetic nanoparticles which are too small (<100 nm, often comprised of single domain cores <20 nm) to be sufficiently targeted [30], [31]. Polyethyleneimine (PEI) has been used as a multifunctional capping agent for further chemical modification of SPIONs to improve their suitability for use in MRI and gene/drug delivery [32], [33], [34]. It is a branched biopolymer with a high density of amine groups. The primary amines of PEI can effectively absorb protons to produce positive charge, rendering a strong affinity to cells [35], [36], [37].
In this work, we describe the formation and characterization of 5-FU loaded Fe3O4-β-CD, Fe3O4-β-CD-PEG and Fe3O4-β-CD-PEG-PEI nanocomposites as a possible and potential drug carrier for targeted drug delivery. Furthermore, the drug release properties, drug encapsulation efficiency (EE), loading capacity (LC) and in-vitro cytotoxicity for 5-FU loaded Fe3O4-β-CD, Fe3O4-β-CD-PEG and Fe3O4-β-CD-PEG-PEI nanocomposites were also investigated.
Section snippets
Materials
Ferric chloride hexahydrate (FeCl3·6H2O, purity >99%), ferrous chloride tetrahydrate (FeCl2·4H2O, purity >99%), ammonium hydroxide (25 wt%), polyethyleneglycol-4000 (PEG), polyethyleneimine(PEI), β-cyclodextrin (β-CD), light liquid paraffin oil, analytical reagent grade epichlorohydrin (EPI), Span 80, phosphate buffered saline (PBS), 5-Fluorouracil, 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO) were purchased from Sigma–Aldrich (St. Louis,
Particle size and zeta potential
Particle size and surface charge are considered to be the most important criteria that have to be focused in order to have an effective drug delivery. Particle size of the nanoparticles plays a vital role in targeting anti-cancer drugs in tumor tissues. Table 1 displays the particle size and zeta potential of the 5-FU loaded Fe3O4-β-CD, Fe3O4-β-CD-PEG and Fe3O4-β-CD-PEG-PEI nanoparticles. The particle size for the 5-FU loaded (10%) Fe3O4-β-CD, Fe3O4-β-CD-PEG and Fe3O4-β-CD-PEG-PEI nanoparticles
Discussion and conclusions
As shown in Table 1, an increase in the percentage of 5-FU encapsulation caused a slight increase in the size of the nanoparticles. Also the coordination of PEG and PEI with Fe3O4-β-CD-5-FU increased the size of the nanoparticles. Therefore, the increase in size could be attributed to the loading of 5-FU on the nanocarrier particles. Besides, Table 1. Shows that the drug loaded nanoparticles had negative charges therefore electrostatic repulsion was enough to stabilize the nanoparticles. Such
Conflicts of interest
The authors have declared no conflict of interest
Acknowledgements
One of the authors (G. Prabha) would like to acknowledge the National Centre for Nanoscience and Nanotechnology, University of Madras, Chennai, India for providing the necessary instrumental facilities and the dedicated support of C. Vijaya Bhaskar
References (45)
Magnetic nanoparticles
J. Magn. Magn. Mater.
(1999)- et al.
Facile synthesis of magnetic iron oxide nanoparticles using 1-methyl-2-pyrrolidone as a functional solvent
Colloids Surf. A
(2009) - et al.
from iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications
Pharmacol. Res.
(2010) - et al.
Synthesis of ultra-small magnetic iron oxide nanoparticles and study of their colloid and surface chemistry
J. Magn. Magn. Mater.
(2009) - et al.
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy
Adv. Drug Deliv. Rev.
(2011) - et al.
Large enhancements of magnetic anisotropy in oxide-free iron nanoparticles
J. Magn. Magn. Mater.
(2013) - et al.
Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration
Biomaterials
(2010) - et al.
Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles
J. Colloid Interface Sci.
(2004) - et al.
Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells
Biomaterials
(2005) - et al.
Methodology description for detection of cellular uptake of PVA coated superparamagnetic iron oxide nanoparticles (SPION) in synovial cells of sheep
J .Magn. Magn. Mater.
(2005)
Microsphere design for the colonic delivery of 5-fluorouracil
J. Controlled Release
Sustained release of antineoplastic drugs from chitosan-reinforced alginate microparticle drug delivery systems
Int. J. Pharm.
5-Fluorouracil encapsulated alginate beads for the treatment of breast cancer
Int. J. Pharm.
Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective
Adv. Drug Deliv. Rev.
Copper (ii) coordination properties of the intergrin ligand sequence phsrn and its new beta-cyclodextrin conjugates
J. Inorg. Biochem.
Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging, Int
J. Pharm.
Determination of nanoparticle vehicle unpacking by MR imaging of T2 magnetic relaxation switch
Biomaterials
Adhesion and proliferation of cells on new polymers modified biomaterials
Bio. Electrochem.
Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles
Int. J. Pharm.
Chitosan nanoparticles loaded with dorzolamide and pramipexole
Carbohydr. Polym.
Positively charged nanoparticles for improving the oral bioavailability of cyclosporine-A
Int. J. Pharm.
Preparation and characterization of hydrophobic superparamagnetic magnetite gel
J. Magn. Magn. Mater.
Cited by (54)
Utilizing nanotechnology and advanced machine learning for early detection of gastric cancer surgery
2024, Environmental ResearchTargeted anticancer drug delivery via surface engineered iron oxide nanoparticles: A recent update
2023, Journal of Drug Delivery Science and TechnologyGlycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier
2022, International Journal of Biological MacromoleculesCitation Excerpt :Moreover, β-cyclodextrin (β-CD) is a cyclic oligosaccharide with a hydrophilic surface and a hydrophobic inner cavity. Due to its selective inclusion and excellent biocompatibility, β-CD and its derivatives, as drug delivery carriers, are widely used to improve the solubility and bioavailability of water-insoluble drugs [20–22]. In this work, we design a new liver-targeted delivery system by integrating GA and Pu with β-CD to form GCDPu NPs.
Dual targeting procyanidin nanoparticles with glutathione response for colitis treatment
2022, Chemical Engineering Journal